Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples.

Rudge TL Jr, Sankovich KA, Niemuth NA, Anderson MS, Badorrek CS, Skomrock ND, Cirimotich CM, Sabourin CL.

PLoS One. 2019 Apr 18;14(4):e0215457. doi: 10.1371/journal.pone.0215457. eCollection 2019.


Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.

Matassov D, Mire CE, Latham T, Geisbert JB, Xu R, Ota-Setlik A, Agans KN, Kobs DJ, Wendling MQS, Burnaugh A, Rudge TL Jr, Sabourin CL, Egan MA, Clarke DK, Geisbert TW, Eldridge JH.

J Virol. 2018 Jan 17;92(3). pii: e01190-17. doi: 10.1128/JVI.01190-17. Print 2018 Feb 1.


Human butyrylcholinesterase efficacy against nerve agent exposure.

Reed BA, Sabourin CL, Lenz DE.

J Biochem Mol Toxicol. 2017 May;31(5). doi: 10.1002/jbt.21886. Epub 2017 Feb 22. Review.


Characterization of a Mouse Model of Oral Potassium Cyanide Intoxication.

Sabourin PJ, Kobs CL, Gibbs ST, Hong P, Matthews CM, Patton KM, Sabourin CL, Wakayama EJ.

Int J Toxicol. 2016 Sep;35(5):584-603. doi: 10.1177/1091581816646973. Epub 2016 May 11.


Neurobehavioral and Cardiovascular Effects of Potassium Cyanide Administered Orally to Mice.

Hawk MA, Ritchie GD, Henderson KA, Knostman KA, Roche BM, Ma ZJ, Matthews CM, Sabourin CL, Wakayama EJ, Sabourin PJ.

Int J Toxicol. 2016 Sep;35(5):604-15. doi: 10.1177/1091581816646974. Epub 2016 May 11.


Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.


Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.

Trefry JC, Wollen SE, Nasar F, Shamblin JD, Kern SJ, Bearss JJ, Jefferson MA, Chance TB, Kugelman JR, Ladner JT, Honko AN, Kobs DJ, Wending MQ, Sabourin CL, Pratt WD, Palacios GF, Pitt ML.

Viruses. 2015 Dec 19;7(12):6739-54. doi: 10.3390/v7122969.


Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.

Schiffer JM, Chen L, Dalton S, Niemuth NA, Sabourin CL, Quinn CP.

Vaccine. 2015 Jul 17;33(31):3709-16. doi: 10.1016/j.vaccine.2015.05.091. Epub 2015 Jun 10.


Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Chen L, Schiffer JM, Dalton S, Sabourin CL, Niemuth NA, Plikaytis BD, Quinn CP.

Clin Vaccine Immunol. 2014 Nov;21(11):1512-20. doi: 10.1128/CVI.00469-14. Epub 2014 Sep 3.


Accumulation of CD11b⁺Gr-1⁺ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses.

Long JP, Kotur MS, Stark GV, Warren RL, Kasoji M, Craft JL, Albrecht RA, García-Sastre A, Katze MG, Waters KM, Vasconcelos D, Sabourin PJ, Bresler HS, Sabourin CL.

Arch Virol. 2013 Jun;158(6):1305-22. doi: 10.1007/s00705-012-1593-3. Epub 2013 Feb 9.


A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.


Macaque proteome response to highly pathogenic avian influenza and 1918 reassortant influenza virus infections.

Brown JN, Palermo RE, Baskin CR, Gritsenko M, Sabourin PJ, Long JP, Sabourin CL, Bielefeldt-Ohmann H, García-Sastre A, Albrecht R, Tumpey TM, Jacobs JM, Smith RD, Katze MG.

J Virol. 2010 Nov;84(22):12058-68. doi: 10.1128/JVI.01129-10. Epub 2010 Sep 15.


Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.

Clement KH, Rudge TL Jr, Mayfield HJ, Carlton LA, Hester A, Niemuth NA, Sabourin CL, Brys AM, Quinn CP.

Clin Vaccine Immunol. 2010 Nov;17(11):1753-62. doi: 10.1128/CVI.00174-10. Epub 2010 Aug 25.


Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model.

Chang YC, Sabourin CL, Lu SE, Sasaki T, Svoboda KK, Gordon MK, Riley DJ, Casillas RP, Gerecke DR.

J Biochem Mol Toxicol. 2009 May-Jun;23(3):172-84. doi: 10.1002/jbt.20275.


Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, García-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3455-60. doi: 10.1073/pnas.0813234106. Epub 2009 Feb 13.


Evaluation of Acute Immunotoxicity of Aerosolized Aflatoxin B(1) in Female C57BL/6N Mice.

Sabourin PJ, Price JA, Casbohm SL, Perry MR, Tuttle RS, Rogers JV, Rowell KS, Estep JE, Sabourin CL.

J Immunotoxicol. 2006 Jan 1;3(1):11-20. doi: 10.1080/15476910500468635.


Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.

Rogers JV, Choi YW, Giannunzio LF, Sabourin PJ, Bornman DM, Blosser EG, Sabourin CL.

Microb Pathog. 2007 Aug-Sep;43(2-3):67-77. Epub 2007 Apr 20.


Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed.

Rogers JV, Casbohm SL, Giannunzio LF, Sinnott LT, Rust SW, Brys AM, Durnford JM, Quinn CP, Robinson DM, Hunt RE, Estep JE, Sabourin CL.

Vaccine. 2006 Apr 24;24(17):3609-17. Epub 2006 Feb 9.


Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure.

Shakarjian MP, Bhatt P, Gordon MK, Chang YC, Casbohm SL, Rudge TL, Kiser RC, Sabourin CL, Casillas RP, Ohman-Strickland P, Riley DJ, Gerecke DR.

J Appl Toxicol. 2006 May-Jun;26(3):239-46.


Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint.

Dillman JF 3rd, Hege AI, Phillips CS, Orzolek LD, Sylvester AJ, Bossone C, Henemyre-Harris C, Kiser RC, Choi YW, Schlager JJ, Sabourin CL.

J Pharmacol Exp Ther. 2006 Apr;317(1):76-87. Epub 2005 Dec 23.


Supplemental Content

Loading ...
Support Center